Fig. 5
From: Bioinformatic analysis reveals MIR502 as a potential tumour suppressor in ovarian cancer
NRF1 acted as a transcription factor of CLCN5. a The upper part of the picture shows the NRF1 binding sequence, and the lower table shows the prediction of NRF1 binding sites within the promoter region of CLCN5 provided by the JASPAR database. b Positive correlation of the expression levels of CLCN5 and NRF1. c Analysis of CLCN5 ChIP-seq data from K562, T47D, HepG2, HCC1954 and HeLa cells at the CLCN5 promoter from Cistrome Data Browser databases